Skip to content

Effect of Mindfulness Based Relapse Prevention Model on Impulsivity, Distress Tolerance and Relapse Prevention in Opioid dependent Patient

Effect of Mindfulness Based Relapse Prevention Model on Impulsivity, Distress Tolerance and Relapse Prevention in Opioid dependent Patient

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2016010525870N1
Enrollment
70
Registered
2016-01-20
Start date
2014-08-04
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Opioid dependency. F11 Mental and behavioural disorders due to use of opioids

Interventions

Mindfulness Based Relapse Prevention ? 8 session? 2 hours? intervention group.
Behavior
Mindfulness Based Relapse Prevention ? 8 session? 2 hours? intervention group

Sponsors

Vice chancellor for research of Kashan University of Medical Sciences and health service
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Beyond the period of detoxification ; cycle degree; Age 20-40 years; at least once history of relapse; referred by a psychiatrist (diagnosis of drug dependence) based on DSM-IV; After more than a week of successful detoxification. Exclusion criteria: use Anti-psychotic drugs; having a long-term dependency on a substance simultaneously; the absence of more than two session; Get a history of other therapy during the past month

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Impulsivity. Timepoint: before intervention, After intervention, 1 month after intervention. Method of measurement: Barratt Impulsiveness scale.;Distress Tolerance. Timepoint: Before intervention ?After intervention? 1 month After intervention?. Method of measurement: Simon JS ? Gaher Distress Tolerance scale.;Relapse. Timepoint: Before intervention ?After intervention? 1 month After intervention?. Method of measurement: morphine kit.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMehdi Yaghobi

Kashan University of Medical Sciences and health service

mehdiyaghobi13110@gmail.com;yaghobi-me@mail.kaums.ac.ir+98 31 5554 0021

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026